Esophageal ulceration associated with 13-cis-retinoic acid therapy in patients with Barrett's esophagus.
暂无分享,去创建一个
[1] D. Alberts,et al. 13-Cis-retinoic acid: pharmacology, toxicology, and clinical applications for the prevention and treatment of human cancer. , 1985, Critical reviews in oncology/hematology.
[2] W S Payne,et al. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. , 1985, The New England journal of medicine.
[3] T. Nigra,et al. General clinical toxicology of oral retinoids. , 1982, Journal of the American Academy of Dermatology.
[4] David F. Cruess,et al. Barrett's esophagus: A prevalent, occult complication of gastroesophageal reflux disease , 1987 .
[5] P. Manley,et al. Isotretinoin-associated proctosigmoiditis. , 1987, Gastroenterology.
[6] M. Savary,et al. Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. , 1975, The Journal of thoracic and cardiovascular surgery.
[7] N. Barrett. Chronic peptic ulcerz of the œophagus and ‘œsophagitis’ , 1950 .
[8] J. Cameron,et al. Adenocarcinoma in Barrett's esophagus after elimination of gastroesophageal reflux , 1984 .